Where Does Kratom Come From? A Guide to Origin, Import Records and Supplier Traceability

The short answer

Kratom comes from the leaves of Mitragyna speciosa, a
tropical tree indigenous to Southeast Asia. Government and scientific
sources identify Thailand, Malaysia, Myanmar and other parts of the
region as part of its traditional range. But that botanical answer is
only the beginning of a modern product’s story.

A pouch sold by a U.S. company may involve several different
locations. Trees may be grown and harvested in one country. Leaves may
be dried by a farmer or village collector, consolidated by a regional
trader, milled in another facility, exported by a separate company,
imported by a U.S. consignee, treated or blended domestically, and
finally packaged by the brand shown on the label. Capsules add another
production step because powder must be encapsulated and the shell may
come from a different supplier.

That is why a U.S. business address does not prove that the leaf was
grown in the United States. A strain name does not prove a particular
village, river, island or farm. A country name on a product page does
not establish lot-level traceability. A laboratory report can describe
the sample tested without revealing where the trees grew. “Packed in
Colorado,” “distributed by a U.S. company” and “product of Indonesia”
answer different questions.

The useful question is not simply, “Where does kratom come from?” It
is: What evidence connects this specific retail lot to its
stated botanical material, harvest or processing origin, importer,
manufacturing steps and finished-product tests?

Five different meanings of
“origin”

Origin claims become confusing when one word is used for several
facts. Separate these five meanings before evaluating a label or
website.

1. Botanical origin

This means the natural geographic association of the species.
Mitragyna speciosa is a Southeast Asian tree in the coffee
family, Rubiaceae. Botanical origin describes the species and region; it
does not authenticate a commercial package.

2. Agricultural or harvest
origin

This is where the leaves in a particular lot were actually grown and
collected. A useful harvest-origin record may identify a country,
province or district, collector group, farm or collection area, harvest
window and raw-material lot. Public retail labels rarely show all of
that information.

3. Processing origin

Leaves do not become consistent retail powder by geography alone.
Processing may include sorting, washing or other preparation, drying,
milling, sieving, microbial-reduction treatment, blending, encapsulation
and packaging. These steps may occur in several places.

4. Customs country of origin

U.S. Customs and Border Protection applies country-of-origin marking
rules to imported articles and their containers. Unless an exception
applies, 19 CFR §134.11 generally requires the English name of the
country of origin to be marked conspicuously for the ultimate purchaser.
Repacking can create additional marking obligations. This customs
concept is important, but it is not a complete farm-to-package
history.

5. Brand or seller location

The address on a dietary-supplement-style label may identify the
manufacturer, packer or distributor. FDA’s labeling guide explains that
a label ordinarily includes the name and place of business of one of
those entities. That address identifies a responsible business location;
it does not necessarily identify the grower, foreign processor,
importer, testing laboratory or country in which the leaf
originated.

Where the kratom tree grows

The most defensible broad statement is that Mitragyna
speciosa is indigenous to tropical Southeast Asia. DEA has
specifically named Thailand, Malaysia and Myanmar while recognizing
other areas in the region. Peer-reviewed botanical and pharmacology
literature also consistently describes the species as native or
indigenous to Southeast Asia.

This regional description should not be turned into an unsupported
claim about a retail lot. A company may use a familiar country or
location name because it describes a supplier relationship, a
traditional market term, a blend name or a marketing story. Only records
tied to the lot can establish what that name means for the package in
hand.

Growing conditions can vary within a country and across harvest
windows. Rainfall, drainage, soil, plant maturity, leaf handling and
drying conditions can all differ. Geography alone therefore cannot
establish alkaloid content, microbial quality, heavy-metal results,
moisture, identity or legal compliance. Those questions require
appropriate specifications, sampling, testing and records.

The modern kratom supply
chain

A simple “farm to pouch” image can conceal how many custody and
transformation points exist. A realistic chain may look like this:

1. Trees are grown or leaves are collected.
2. Leaves from one or more plots or collection areas are
   harvested.
3. Material is sorted and dried.
4. Multiple drying lots may be consolidated.
5. Dried leaf is milled and sieved into powder.
6. Powder may undergo a microbial-reduction step.
7. Lots may be blended to achieve color, texture, inventory or internal
   specifications.
8. An exporter prepares commercial and shipping records.
9. A U.S. importer or consignee makes entry.
10. Bulk material is received, sampled, tested, quarantined or
    released.
11. Powder may be repacked, blended again or encapsulated.
12. A finished-product lot code is assigned.
13. The retail unit enters storage and distribution.

Not every company uses every step, and the order can differ. The
point is that each consolidation or transformation can change the
meaning of “one lot.” If five raw-leaf lots become one milling lot, the
finished powder cannot honestly be traced to a single farm unless
records support that relationship. If one bulk lot is divided among
several U.S. packers, the retail codes should still link back to the
bulk material and associated decisions.

A map is not a traceability
system

Photos of farms, rivers or drying racks can provide context, but they
do not connect a retail package to the scene shown. Traceability
requires identifiers and records. At minimum, a company should be able
to connect the finished lot to the received material, supplier,
processing history and relevant test or release records.

A supplier invoice
is not the full history

An invoice can identify who sold material to the buyer. It may not
identify the actual grower, drying facility, mill, treatment facility or
earlier consolidators. A strong program follows the chain far enough to
understand which entities controlled important hazards and product
attributes.

A COA is not an origin
certificate

A certificate of analysis reports results for a submitted sample. It
may list a client, product description, lot number and laboratory
accession number. Unless origin authentication was part of the method
and the sample-to-lot connection is documented, the COA does not
independently prove a country, farm or harvest location.

What U.S.
import rules do—and do not—tell consumers

FDA Import Alert 54-15

As of August 17, 2026, FDA’s current Import Alert 54-15 addresses
detention without physical examination of dietary supplements and bulk
dietary ingredients that are or contain Mitragyna speciosa or
kratom. The alert describes imported forms including capsules, whole
leaves, processed leaves, resins, extracts, powdered leaves and bulk
liquids made from leaf extracts.

The alert is guidance to FDA field personnel. Its red-list and
center-review procedures should not be rewritten as the claim that every
kratom shipment is physically inspected, automatically seized or tested
by FDA. “Detention without physical examination” also does not mean FDA
has certified competing products that are not detained.

For product literacy, the practical lesson is straightforward: the
presence of imported kratom in U.S. commerce is not evidence that FDA
approved, certified or precleared the shipment. FDA states separately
that it does not approve, certify, license or otherwise sanction
individual food importers, products, labels or shipments in advance.

Foreign Supplier
Verification Programs

FDA’s Foreign Supplier Verification Programs rule generally requires
covered food importers to use risk-based activities to verify that
imported food meets applicable U.S. requirements. The rule includes
supplier approval, hazard and supplier-performance evaluation,
verification activities, corrective actions and records. FDA identifies
on-site audits, sampling and testing, and review of supplier food-safety
records as possible verification activities.

Dietary supplements receive specialized treatment under the FSVP
framework. The exact obligations depend on whether the imported item is
a finished supplement or a component and on how the importer meets
applicable dietary-supplement current good manufacturing practice
requirements. Modified requirements and exemptions may also apply. It is
therefore inaccurate to say that every kratom importer must use the same
audit or testing schedule.

Consumers usually will not receive the importer’s complete FSVP file.
They can still ask useful questions:

• Who is the U.S. importer or consignee?
• Does the brand know the legal name and physical location of the
  foreign supplier?
• Which entity dries, mills and treats the material?
• How is each approved supplier connected to each received lot?
• What verification activity applies to the identified hazards?
• What happens when a supplier, facility, process or country
  changes?

A polished certificate labeled “FSVP compliant” is not, by itself, a
complete answer. FSVP is a program of decisions, verification and
records—not a generic product approval badge.

Country-of-origin marking

Country-of-origin marking is primarily a customs requirement. Under
19 CFR Part 134, an imported article or its container generally must
indicate the country of origin to the ultimate purchaser unless an
exception applies. Special provisions address articles that are repacked
or manipulated after importation.

This creates several important distinctions:

• “Product of Indonesia” is an origin statement.
• “Imported by Company X, Denver, Colorado” identifies the importer
  and address.
• “Distributed by Company Y” identifies the marketer or
  distributor.
• “Packed in Colorado” describes a packaging step.
• “Tested in the USA” describes a laboratory location.

None of the last four statements automatically changes where the
botanical ingredient originated.

Country-of-origin analysis can become fact-specific when imported
material is substantially transformed, incorporated into another product
or repacked. Brands should obtain customs advice for their actual
process instead of copying language from another label. Consumers should
avoid treating one short origin phrase as a complete manufacturing
narrative.

“Made in USA” is a separate
claim

The Federal Trade Commission’s Made in USA Labeling Rule governs
unqualified U.S.-origin claims. FTC has reiterated that products
advertised as “Made in USA” must meet its “all or virtually all”
standard. A product packaged domestically from imported botanical leaf
should not be assumed to qualify for an unqualified claim merely because
milling, blending, encapsulation or packaging occurred in the United
States.

Qualified statements can communicate specific steps more precisely:
for example, “Packaged in Colorado with imported botanical ingredients,”
if true and appropriately substantiated. The right wording depends on
the facts and legal review.

How to read common origin
statements

“Sourced from Southeast Asia”

This is geographically broad. It may be accurate while revealing
little about the supplier, country, processor or lot. Ask whether the
brand can identify the country and relevant facilities internally, even
if it does not publish proprietary supplier names.

“Indonesian kratom”

This could mean grown in Indonesia, exported from Indonesia,
processed there, purchased from an Indonesian supplier or simply sold
under a market name. The seller should define the claim and retain
records supporting it.

“Direct from farmers”

“Direct” is not a standardized chain-of-custody term. Ask which
intermediaries remain. A brand might buy from a cooperative or exporter
that works with farmers; that can be a legitimate model, but it is not
literally the same as buying separately from each farm.

“Single origin”

The phrase needs a declared boundary. Does it mean one country,
province, cooperative, collection area, farm, harvest window or milling
lot? A single-country blend can still combine material from many farms
and dates.

“Wild harvested”

This claim should identify what “wild” means, who verifies it and how
collection areas are controlled. It does not prove purity,
sustainability, legal harvest or consistent chemistry.

“Small batch”

Batch size is meaningful only when the company defines it. A small
retail packaging run can originate from a very large bulk lot. Ask
whether “small batch” refers to harvest, milling, blending, treatment,
encapsulation or packaging.

“Lab tested in the USA”

This can describe the testing location, not the leaf origin. Review
the report, laboratory, sample ID and retail lot connection
separately.

“Manufactured for” or
“distributed by”

These phrases identify the business whose name appears on the label
when it is not necessarily the physical manufacturer. They should not be
read as proof that the named company grew, imported, milled or
encapsulated the product.

Product format
changes the origin question

Whole or crushed leaf

The chain may preserve more botanical features, but whole appearance
does not prove origin. Records should still connect the material to a
supplier, lot and relevant handling steps.

Powder

Milling can combine material and erase visible features used in basic
botanical examination. A powder lot needs clear incoming-material
identity, milling and blending records, and finished-lot linkage.

Pure-leaf capsules

The capsule format does not make the contents an extract. Kiody
describes its capsules as approximately 500 mg of pure botanical leaf
per capsule, not concentrated extract. Origin review should address both
the powder lot and the encapsulation/packaging lot. Capsule shells and
excipients may have separate suppliers and origins.

Tea bags or drink mixes

These may contain leaf plus flavors, sweeteners or other ingredients.
“Kratom origin” addresses only one component unless the claim clearly
covers the entire formulation.

Extracts

An extract adds raw-material, extraction and standardization
questions. The country in which extraction occurred may differ from the
country where the leaf grew. A ratio such as 10:1 does not prove
country, process yield or final alkaloid content.

Enhanced products

Enhanced leaf or blends combine botanical material with added extract
or alkaloid-rich material. Each component needs identity and origin
control. A leaf COA cannot automatically represent the added
fraction.

Concentrated
7-OH and manufactured derivatives

Products marketed around concentrated, enhanced, synthesized or
semi-synthesized 7-OH are not interchangeable with ordinary botanical
leaf. Their “botanical origin” story can be especially misleading if the
final active material was produced or enriched through chemical
processing.

Kiody does not sell concentrated 7-OH. As of September 3, 2026, HHS
is accepting information through September 10 on a proposed federal
threshold for temporary scheduling of 7-OH. That proceeding is pending;
it is not a final threshold rule. Separately, DEA’s temporary Schedule I
order for mitragynine pseudoindoxyl, MGM-15 and MGM-16 took effect
August 26, 2026 and runs through August 26, 2028 unless extended or made
permanent. The derivative order does not place ordinary botanical leaf
into federal Schedule I.

Country of origin does not override federal, state or local product
restrictions. A product does not become lawful because its leaf came
from a traditional growing region or because its final package uses
botanical imagery.

The evidence ladder for
origin claims

Not all origin evidence has equal value. This ladder helps organize
it without pretending that one document proves everything.

Level 1: marketing language

Examples include “premium Indonesian,” “rainforest grown,” “farm
fresh” and an image of farmers. These may be true, but they are claims
rather than verification.

Level 2: supplier identity

The brand knows the supplier’s legal name, address and role. This is
better than an anonymous broker, but it still may not identify the
grower or processing facilities.

Level 3: transaction records

Purchase orders, commercial invoices, packing lists, bills of lading
and receiving records connect a shipment to businesses, dates and
quantities. They help reconstruct custody but may not establish
agricultural origin alone.

Level 4: lot-linked
production records

Raw-material lot numbers, harvest or collection information, drying
and milling records, consolidation logs, treatment records and
certificates tied to the received lot provide a stronger chain.

Level 5:
independent and reconciled verification

The strongest program reconciles supplier records with receiving
observations, sampling, identity work, contaminant testing, mass
balance, audit evidence and finished-product release. Independent
evidence does not remove the need for internal review.

A 12-step origin and
traceability review

Step 1: Record the retail lot

Photograph or transcribe the product name, lot or batch code, package
size and best-by or manufacturing date. Without a unique lot, origin
review becomes a general brand discussion.

Step 2: Identify the
product category

Determine whether the product is whole leaf, powder, pure-leaf
capsules, extract, enhanced leaf, a multi-ingredient blend, concentrated
7-OH or another derivative. Different categories require different
supply-chain records.

Step 3: Separate every
public claim

Copy the exact wording. Do not combine “Indonesian,” “packed in
Colorado” and “lab tested in Nevada” into one vague origin
impression.

Step 4: Identify the
named business role

Does the label say manufactured by, manufactured for, packed by,
imported by or distributed by? If it only lists a name and address, ask
what the company actually does.

Step 5: Ask for the
country of origin

Request the country tied to the specific retail lot, not merely the
brand’s normal sourcing region. If the material is blended across
countries, the answer should say so.

Step 6: Map transformation
points

List where drying, milling, microbial reduction, extraction,
blending, encapsulation and final packaging occurred. Mark unknown steps
rather than filling gaps with assumptions.

Step 7: Reconcile
supplier and lot identifiers

The supplier’s raw-material code, exporter code, importer receiving
code, production batch and retail lot may all differ. A cross-reference
record should connect them.

Step 8: Review quantities
and dates

Dates should proceed logically from harvest or production to export,
receipt, processing and packaging. Quantity reconciliation can reveal
whether multiple lots were combined or whether one bulk lot fed several
finished batches.

Step 9: Match testing
to the correct stage

A supplier COA may represent pre-export powder. An importer COA may
represent the received lot. A finished-product COA may represent
post-blending capsules. These results answer different questions.

Step 10: Evaluate
supplier verification

Ask what evidence supports continued approval: audits, records,
testing, complaint history, regulatory history, corrective actions or
another risk-based combination. A first order and a five-year supplier
relationship should not be treated identically without review.

Step 11: Check current
regulatory status

Origin records do not answer whether sales or shipping are permitted
at the destination. Review current federal, state and local rules for
the exact product category.

Step 12: Preserve the review

Keep the label image, webpage claim, lot code, documents reviewed,
questions asked, answers received, unresolved gaps and review date.
Websites and supplier relationships change.

Five fictional origin
reviews

These examples are fictional and are included to show the reasoning
process.

Example 1: U.S. address,
imported leaf

A powder pouch shows a Denver address and says “Distributed by Alpine
Botanicals.” The website calls the product “Indonesian Green.” A
lot-specific document package identifies an Indonesian exporter, a
milling lot and a U.S. receiving record. The powder was tested and
packaged in Colorado.

Assessment: The Denver address identifies the
distributor, not the growing origin. “Product of Indonesia; tested and
packaged in Colorado” would communicate the documented stages more
clearly if legal review confirms the wording.

Example 2: one country, many
farms

A supplier combines dried leaves from 18 small farms into one milling
lot. The U.S. brand calls it “single origin” because all material came
from one Indonesian province.

Assessment: The claim may be understandable only if
the brand defines “single origin” as one province. It would be
misleading if buyers reasonably interpret it as one farm. The lot needs
consolidation and mass-balance records.

Example 3:
supplier COA applied to finished capsules

A foreign supplier tests bulk powder. Six months later, a U.S.
contract packer blends that powder with another lot and fills capsules.
The brand posts the earlier powder COA beside the finished capsules.

Assessment: The document may be authentic but does
not, by itself, represent the blended capsule lot. The brand needs
records connecting both powder inputs to the finished batch and an
appropriate finished-product verification decision.

Example 4: extract
made in a second country

Leaves are reported as grown in Country A. Powder is shipped to
Country B for extraction and standardization, then the extract is
imported to the United States and bottled.

Assessment: “Country A kratom extract” is
incomplete. Agricultural origin, extraction origin and packaging
location should be separated. The extract requires its own composition
and contaminant evaluation.

Example
5: botanical story on a manufactured derivative

A tablet shows leaf artwork and says “inspired by Southeast Asian
tradition.” Laboratory results indicate a named manufactured derivative
rather than ordinary leaf.

Assessment: Cultural or botanical imagery does not
change product identity. If the compound is MGPI, MGM-15 or MGM-16, it
is federally Schedule I under the August 26, 2026 temporary order. Do
not classify the product as ordinary botanical leaf.

Twenty origin and
sourcing warning signs

1. No readable lot or batch code.
2. A U.S. address is presented as proof the leaf was U.S.-grown.
3. “Imported” appears without a country when a country claim is
   otherwise prominent.
4. The company cannot explain whether it is the importer, manufacturer,
   packer or distributor.
5. A strain name is treated as a verified farm location.
6. Farm photographs have no connection to the current lot.
7. “Direct trade” is used while the supply chain includes undisclosed
   brokers.
8. “Single origin” has no defined geographic boundary.
9. One supplier COA is posted for every product and every date.
10. Supplier lot numbers do not reconcile with retail lot numbers.
11. Shipping or receiving dates occur after the claimed packaging
    date.
12. Quantity records cannot explain how much finished product came from
    the bulk lot.
13. The processor changes but the brand’s documents never change.
14. A powder identity result is applied to an extract without
    justification.
15. “Lab tested in America” is used to imply American agricultural
    origin.
16. “GMP facility” is treated as proof of a country-of-origin
    claim.
17. “FDA registered importer” is presented as FDA product approval.
18. A 7-OH or derivative product is described only as traditional
    leaf.
19. The brand will not identify even the country tied to a lot and
    offers no reason.
20. Conflicting label, COA, invoice and website descriptions are left
    unresolved.

One warning sign does not automatically prove deception. It
identifies a question that should be resolved before relying on the
claim.

Origin review worksheet

Use this record for one product and one lot.

Product identity

• Brand and product name:
• Retail format:
• Net quantity:
• Lot or batch code:
• Manufacture, package or best-by date:
• Purchased from:
• Purchase date:
• Review date:

Public claims

• Exact country statement:
• Exact regional statement:
• “Single origin” definition:
• “Wild,” “farm,” “direct” or sustainability claims:
• U.S. processing claim:
• Testing-location claim:
• Manufacturer/packer/distributor wording:

Supply-chain roles

• Grower or collection group:
• Harvest country and region:
• Drying facility:
• Mill:
• Microbial-reduction facility:
• Exporter:
• U.S. importer/consignee:
• U.S. receiver:
• Blender:
• Extractor, if applicable:
• Encapsulator, if applicable:
• Final packer:
• Brand/distributor:

Lot linkage

• Harvest or collection lot:
• Drying lot:
• Milling lot:
• Treatment lot:
• Export/shipment reference:
• Import entry or receiving reference:
• Internal raw-material code:
• Production batch:
• Finished retail lot:
• Cross-reference record reviewed:

Verification

• Supplier qualification status:
• Last supplier review date:
• Audit or other verification activity:
• Identity method and result:
• Microbial testing stage:
• Heavy-metal testing stage:
• Pesticide testing stage:
• Alkaloid testing stage:
• Sampling party:
• COA accession number:
• Release decision:
• Open questions:
• Reviewer and approval:

Frequently asked questions

1. Where does kratom
originally come from?

Mitragyna speciosa is indigenous to tropical Southeast Asia.
That botanical fact does not establish the origin of a specific retail
lot.

2. Is all kratom from
Indonesia?

No. The species is associated with several Southeast Asian countries.
A company making an Indonesian-origin claim should support it for the
relevant lot rather than treating Indonesia as a synonym for all
kratom.

3. Is kratom grown in
the United States?

Individual trees may be cultivated in suitable environments, but a
“Made in USA” or U.S.-grown commercial claim needs product-specific
substantiation. A U.S. company address or domestic packaging step is not
proof that the leaf was grown domestically.

4. Does “Maeng Da”
identify a farm or country?

Not by itself. It is commonly used as a commercial product or style
name. It should not be treated as a certified geographic indication,
cultivar registration or lot-level farm record.

5.
Do Bali, Malay, Hulu, Vietnam and Ketapang names prove origin?

No. Such names may communicate a vendor’s product categories, blends
or sourcing stories. Ask the seller what each term means and what
lot-specific evidence supports any geographic implication.

6. Does vein
color prove where the leaf was grown?

No. Red, green and white classifications are not country-of-origin
verification. Color can also be influenced by leaf selection, drying,
fermentation or blending practices.

7.
Does a U.S. address mean the product was made in America?

No. The address may belong to a manufacturer, packer or distributor.
Review the qualifying wording and separate leaf origin from domestic
processing.

8. What does “packed in the
USA” mean?

It ordinarily describes the packaging step. It does not, without
more, say where the botanical material was grown, dried or milled.

9. What does “tested in the
USA” prove?

It identifies a testing location if accurate. The report must still
be authenticated and matched to the product lot. It does not prove
harvest origin.

10. Can a COA verify
country of origin?

Most routine kratom COAs do not. They report chemical or
microbiological results for a sample. Country authentication would
require a fit-for-purpose method and suitable reference data, plus a
defensible sample chain.

11. Is a
certificate of origin the same as a COA?

No. A commercial or customs certificate of origin addresses origin
information. A COA reports analytical results. Neither automatically
proves the other.

12. Does FDA approve kratom
imports?

FDA states that it does not preapprove, certify, license or otherwise
sanction individual food importers, products, labels or shipments. FDA
Import Alert 54-15 describes agency detention procedures for
kratom-related entries; it is not an approval program.

13. Does
every imported lot get tested at the border?

No. Inspection, sampling and detention decisions vary. Detention
without physical examination specifically means FDA may detain covered
entries based on the alert’s criteria without first physically examining
that shipment.

14. What is an FSVP importer?

Generally, it is the U.S. owner or consignee of food offered for
import, or an eligible U.S. agent or representative when there is no
U.S. owner or consignee at entry. Exact obligations depend on the
product and circumstances.

15.
Does FSVP require an annual audit for every supplier?

No. Verification is risk based. FDA lists audits, sampling and
testing, and records review among possible activities. Dietary
supplements also have specialized provisions. The chosen activity must
be appropriate and documented.

16. Is “direct from
farmers” always better?

Not necessarily. Fewer commercial intermediaries can simplify parts
of the chain, but safety and quality still depend on controls,
specifications, sampling, testing, records and corrective action.

17. Is single-origin
kratom more consistent?

Not automatically. A narrow origin can still vary by tree, harvest
date, drying conditions and processing. Consistency should be evaluated
with defined lots and appropriate data.

18. Does country of
origin predict potency?

Not reliably. Alkaloid content can vary within a country and lot.
Review lot-specific results and the basis of sampling instead of
estimating potency from geography or a strain name.

19.
Does origin prove that a product is contaminant free?

No. Biological, chemical and physical hazards require appropriate
controls and verification. Country reputation is not a substitute for
testing or process evidence.

20. Can
powder from several farms share one lot number?

Yes, if it is intentionally consolidated and the lot is clearly
defined. Records should preserve the contributing lots and show how the
combined lot was controlled.

21. Can
the same bulk lot appear under several brands?

Yes. A processor or distributor may sell portions of one bulk lot to
multiple packers. Each brand still needs traceability between its retail
code and the bulk input.

22. Are pure-leaf capsules
an extract?

No. Encapsulation changes the delivery format, not necessarily the
composition. Kiody’s capsules are approximately 500 mg of pure botanical
leaf per capsule, not concentrated extract.

23.
Does an Indonesian leaf origin make concentrated 7-OH ordinary
kratom?

No. Final composition and manufacturing matter. A concentrated,
enhanced, synthesized or semi-synthesized 7-OH product should not be
classified as ordinary leaf simply because plant material or mitragynine
originated in Southeast Asia.

24. Are
MGPI, MGM-15 and MGM-16 legal if made from kratom?

No. DEA temporarily placed those three substances, along with
specified related forms, in federal Schedule I effective August 26,
2026. Their relationship to kratom does not exempt them.

25. What is
the single most useful origin question?

Ask: “Can you connect this exact retail lot to the received botanical
lot, supplier, country, processing steps and finished-product release
record?” A precise answer is more valuable than a long sourcing
story.

Sources

1. U.S. Food and Drug Administration, Import
   Alert 54-15: Detention Without Physical Examination of Dietary
   Supplements and Bulk Dietary Ingredients That Are or Contain
   Mitragyna speciosa or Kratom, published/updated August 17,
   2026.
2. FDA, FSMA
   Final Rule on Foreign Supplier Verification Programs for Importers of
   Food for Humans and Animals, content current in 2026.
3. FDA, Foreign
   Supplier Verification Programs for Importers of Food for Humans and
   Animals: Guidance for Industry, January 2023.
4. Electronic Code of Federal Regulations, 19 CFR
   Part 134—Country of Origin Marking and §134.11.
5. FDA, Dietary
   Supplement Labeling Guide: Chapter I.
6. FDA, Importing
   Food Products into the United States.
7. Federal Trade Commission, Made
   in USA Labeling Rule and 2025
   compliance warning.
8. Drug Enforcement Administration, DEA
   Announces Intent to Schedule Kratom, August 30, 2016, for the
   agency’s geographic description of the species. DEA later withdrew
   that notice of intent, so it is not presented here as current
   scheduling of botanical leaf.
9. PubMed, A review
   on Mitragyna speciosa as a source of traditional medicine,
   2024/2025 publication record, for botanical-region context.
10. FDA, FDA
    and Kratom, current agency information reviewed September 3,
    2026.
11. Federal Register, 7-Hydroxymitragynine
    Above a Specified Threshold in Schedule I; Extension of Comment
    Period, 91 FR 55104, comments due September 10, 2026.
12. Federal Register, Temporary
    Placement of Mitragynine Pseudoindoxyl, MGM-15 and MGM-16 in Schedule
    I, 91 FR 54948, effective August 26, 2026 through August 26, 2028
    unless extended or made permanent.